Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01328678 · ClinicalTrials.gov registry record
A Study of Vitamin D in Subjects With Alopecia Areata
A clinical trial of Alopecia Areata, sponsored by Avera McKennan Hospital & University Health Center.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT01328678: Completed study of Alopecia Areata, sponsored by Avera McKennan Hospital & University Health Center.
NCT01328678 is a study of Alopecia Areata that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 10 participants, below the 1,955-participant average among 26 other Alopecia Areata trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01328678, a study of Alopecia Areata, has completed, sponsored by Avera McKennan Hospital & University Health Center.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to assess the parathyroid-vitamin D-calcium axis in subjects with alopecia areata. The hypothesis behind this study is that hypovitaminosis D might contribute to the pathogenesis of alopecia areata.
Primary Outcome
This study consists of a single clinic visit. After subject has completed the informed consent process and meets eligibility criteria, a blood sample will be collected. Lab results from this one-time lab draw will be evaluated.
Conditions Studied
Study Locations (1)
South Dakota
- Avera Research Institute - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-08 |
| Est. Completion | 2011-07 |
What the finished NCT01328678 record still lists
NCT01328678 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,955-participant average among 26 other Alopecia Areata trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Alopecia Areata appearing as the primary indexed condition, and to 0 interventions.
NCT01328678 reports a single indexed study location in South Dakota.
Frequently Asked Questions
What is clinical trial NCT01328678 about?
NCT01328678 is a clinical study titled "A Study of Vitamin D in Subjects With Alopecia Areata". The objective of this study is to assess the parathyroid-vitamin D-calcium axis in subjects with alopecia areata. The hypothesis behind this study is that hypovitaminosis D might contribute to the pathogenesis of alopecia areata.
What is the current status of trial NCT01328678?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2009-08. Estimated completion is 2011-07.
What conditions does trial NCT01328678 study?
This clinical trial studies the following conditions: Alopecia Areata.
Who is sponsoring clinical trial NCT01328678?
This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01328678 being conducted?
This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alopecia Areata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01328678's enrollment target sits among peer trials
10 26th of 26 higher than 1 of 26 other Alopecia Areata trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alopecia Areata trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
RECRUITING · Phase 2
-
A Study of LAD603 in Adults With Alopecia Areata
RECRUITING · Phase 2
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
RECRUITING · Phase 1
-
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
RECRUITING
-
Dupilumab in the Treatment of Pediatric Alopecia Areata
RECRUITING · Phase 2
-
Intralesional Cyclosporine for Alopecia Areata
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia